A Model Based on Noninvasive Markers Predicts Very Low Hepatocellular Carcinoma Risk After Viral Response in Hepatitis C Virus-Advanced Fibrosis.

Sonia Alonso LópezMaría Luisa ManzanoFrancisco GeaMaría Luisa GutiérrezAdriana Maria AhumadaMaría José DevesaAntonio OlveiraBenjamin Arturo PoloLaura MárquezInmaculada FernándezJuan Carlos Ruiz CoboLaura RayónDaniel RiadoSonia IzquierdoClara UsónYolanda RealDiego RincónConrado M Fernández-RodríguezRafael Bañares

Published in: Hepatology (Baltimore, Md.) (2020)

A combination of baseline and dynamic changes in noninvasive markers may help to identify patients with a very low risk of HCC development after SVR.

Keyphrases

hepatitis c virus
human immunodeficiency virus
sars cov
hiv infected
antiretroviral therapy
breast cancer risk